FDA approval may spell trouble for Canadian patients

The FDA’s Florida decision might wind up limiting Canadians’ access to pharmaceutical medicines as long as Canadian drug prices remain well below prices in the United States.

U.S. Food and Drug Administration Commissioner Robert M. Califf, left, and Health Minister Mark Holland. Legalized importing of drugs from Canada into the U.S. could reduce the availability of drugs here, but not for the reasons you might think, writes Steven Globerman. Photograph courtesy of the U.S. FDA and The Hill Times photograph by Andrew Meade

Opinion

BY STEVEN GLOBERMAN

January 10, 2024

On Jan. 5, the United States Food and Drug Administration (FDA) approved Florida’s request to import specific drugs directly from Canada. This is the first such approval by the FDA, ...

To keep reading, subscribe and become a political insider.

Only $7.76 a week for an annual subscription.

Enjoy unlimited website access and the digital newspaper.

Cancel anytime.

Already a Subscriber?

Get Weekend Point of View Newsletter

A round up of the past weekâ€™s opinion writers and columnists on Saturdays and Sundays.

By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy